Dupont Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
Dupont Capital Management's CDNA Position: Q2 2022 in Review
Dupont Capital Management sold out of CareDx (CDNA) in Q2 2022, closing a stake of 4,041 shares — an estimated $149K sold.
Dupont Capital Management first reported a position in CDNA in Q2 2019 and held it in 4 quarters. The position peaked at $666K in Q2 2019. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.
- Dupont Capital Management reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
- Dupont Capital Management sold 4,041 CareDx shares in Q2 2022, an estimated $149K.
- Dupont Capital Management first reported a position in CareDx in Q2 2019 and held it in 4 quarters.
- Dupont Capital Management's CareDx position peaked at $666K in Q2 2019.
- 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.
Based on Dupont Capital Management's 13F filing for Q2 2022, filed 26 Jul 2022.